This report shows the distribution of the review status of subjects in a study.
Before you can run this report, you must have identified and analyzed data from patients of interest, and indicated review status using the Profile Subjects report.
Running this report for the Nicardipine sample setting generates the report shown below.
[The Distribution section contains the following elements:
|
•
|
Review status can be changed when reviewing subjects from the Patient Profiler. In this example, 4 out of 902 subjects (0.4%) have been reviewed in the Patient Profiler, all have been newly added to the review, none of them have user notes, and 100 subjects (11.1%) have system notes.
Note: The review flag of a reviewed subject who is found to have new or modified records with a snapshot update is switched to unreviewed.
Note: System notes are automatically generated to record the time stamp of study creation and modification events.
|
•
|
Profile Subjects: Select subjects and click
 to generate the patient profiles. See Profile Subjects for additional information. |
|
•
|
Show Subjects: Select subjects and click
 to open the ADSL (or DM if ADSL is unavailable) of selected subjects. |
|
•
|
Cluster Subjects: Select subjects and click
 to cluster them using data from available covariates. See Cluster Subjects for additional information. |
|
•
|
Demographic Counts: Select subjects and click
 to create a data set of USUBJIDs, which subsets all subsequently run reports to those selected subjects. The currently available filter data set can be applied by selecting Apply Subject Filter in any report dialog. |
|
•
|
Click
 to view the associated data tables. Refer to View Data for more information. |
|
•
|
Click
 to generate a standardized pdf- or rtf-formatted report containing the plots and charts of selected sections. |
|
•
|
Click
 to take notes, and store them in a central location. Refer to Add Notes for more information. |
|
•
|
Click
 to read user-generated notes. Refer to View Notes for more information. |
|
•
|
Click the arrow to reopen the completed report dialog used to generate this output.
|
|
•
|
Click the gray border to the left of the Options tab to open a dynamic report navigator that lists all of the reports in the review. Refer to Report Navigator for more information.
|
The primary goal of clinical trials is to distinguish treatment effects when reporting and analyzing trial results. Treatments are defined by specific values in the treatment or comparison variables of the CDISC models. These variables are specified in this report using the Treatment or Comparison Variable to Use andTreatment or Comparison Variable options.
Available variables include Planned, which is selected when the treatments patients received exactly match what was planned and Actual, which is selected when treatment deviates from what was planned.
You can also specify a variable other than the ARM or TRTxxP (planned treatment) or ACTARM or TRTxxA (actual treatment) from the CDISC models as a surrogate variable to serve as a comparator. Finally you can select None to plot the data without segregating it by a treatment variable.
Note: Subjects not meeting filtering criteria remain in the domains but notes associated with them are not surfaced in the viewer.
Subject-specific filters must be created using the Create Subject Filter report prior to your analysis.